We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RR:NASDAQRichtech Robotics Inc. Analysis

Data as of 2026-04-29 - not real-time

$2.41

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Richtech Robotics is trading well above its discounted cash‑flow estimate, with the market price sitting on the higher side of its book value. The 20‑day moving average remains below the 50‑day average, signaling a bearish medium‑term trend, while the RSI hovers around the neutral fifty‑one mark and the MACD histogram is modestly positive, offering mixed short‑term momentum. Volume has been on an upward trajectory, yet the stock exhibits a very high beta and near‑80% 30‑day volatility, underscoring pronounced price swings. Fundamentals are weak: operating margins are deeply negative, earnings per share are in the red, and cash flow from operations is negative, though the balance sheet is bolstered by a sizable cash balance and minimal debt. Recent material news highlights a new European distribution agreement that could open additional revenue streams, and a $38.7 million private placement that adds liquidity for growth initiatives. However, the company also faces a pending securities class‑action lawsuit, adding legal uncertainty to the mix.
Given the overvalued pricing relative to intrinsic estimates, the high‑risk technical profile, and the ongoing legal exposure, the near‑term outlook is constrained, while the longer‑term narrative hinges on successful execution of its expansion and product rollout. Investors should weigh the upside from market expansion against the downside from earnings volatility and regulatory scrutiny. The stock’s lack of dividend further limits defensive appeal. Caution is advised, with a bias toward defensive positioning until the company demonstrates consistent profitability and mitigates its legal risks.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish SMA crossover
  • high beta and volatility
  • negative operating margins

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • European distribution partnership
  • substantial cash buffer
  • ongoing legal uncertainty

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential growth in AI‑driven robotics
  • need for consistent profitability
  • exposure to regulatory and safety standards

Key Metrics & Analysis

Financial Health

Revenue Growth-8.80%
ROE-10.63%
ROA-8.06%
Debt/Equity0.18
P/B Ratio1.5
Op. Cash Flow$-7049000
Free Cash Flow$133.0K
Industry P/E30.8

Technical Analysis

TrendBearish
RSI51.3
Support$1.90
Resistance$2.82
MA 20$2.28
MA 50$2.35
MA 200$3.33
MACDBullish
VolumeIncreasing
Fear & Greed Index89.59

Valuation

Fair Value$1.47
Target Price$4.00
Upside/Downside65.98%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta4.08
Volatility78.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.